Sattari Shahab Aldin, Shahbandi Ataollah, Xu Risheng, Hung Alice, Feghali James, Yang Wuyang, Lee Ryan P, Bettegowda Chetan, Huang Judy
1Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.
2Tehran School of Medicine, Tehran University of Medical Science, Tehran, Iran.
J Neurosurg. 2022 Jul 1;138(2):390-398. doi: 10.3171/2022.5.JNS22143. Print 2023 Feb 1.
In microvascular decompression (MVD) surgery through the retrosigmoid approach, the surgeon may have to sacrifice the superior petrosal vein (SPV). However, this is a controversial maneuver. To date, high-level evidence comparing the operative outcomes of patients who underwent MVD with and without SPV sacrifice is lacking. Therefore, this study sought to bridge this gap.
The authors searched the Medline and PubMed databases with appropriate Medical Subject Heading (MeSH) terms and keywords. The primary outcome was vascular-related complications; secondary outcomes were new neurological deficit, cerebrospinal fluid (CSF) leak, and neuralgia relief. The pooled proportions of outcomes and OR (95% CI) for categorical data were calculated by using the logit transformation and Mantel-Haenszel methods, respectively.
Six studies yielding 1143 patients were included, of which 618 patients had their SPV sacrificed. The pooled proportion (95% CI) values were 3.82 (0.87-15.17) for vascular-related complications, 3.64 (1.0-12.42) for new neurological deficits, 2.85 (1.21-6.58) for CSF leaks, and 88.90 (84.90-91.94) for neuralgia relief. The meta-analysis concluded that, whether the surgeon sacrificed or preserved the SPV, the odds were similar for vascular-related complications (2.5% vs 1.5%, OR [95% CI] 1.01 [0.33-3.09], p = 0.99), new neurological deficits (1.2% vs 2.8%, OR [95% CI] 0.55 [0.18-1.66], p = 0.29), CSF leak (3.1% vs 2.1%, OR [95% CI] 1.16 [0.46-2.94], p = 0.75), and neuralgia relief (86.6% vs 87%, OR [95% CI] 0.96 [0.62-1.49], p = 0.84).
SPV sacrifice is as safe as SPV preservation. The authors recommend intentional SPV sacrifice when gentle retraction fails to enhance surgical field visualization and if the surgeon encounters SPV-related neurovascular conflict and/or anticipates impeding SPV-related bleeding.
在经乙状窦后入路的微血管减压术(MVD)中,外科医生可能不得不牺牲岩上静脉(SPV)。然而,这是一种存在争议的操作。迄今为止,缺乏比较牺牲和未牺牲SPV的MVD患者手术结果的高级别证据。因此,本研究旨在填补这一空白。
作者使用适当的医学主题词(MeSH)和关键词搜索了Medline和PubMed数据库。主要结局是血管相关并发症;次要结局是新的神经功能缺损、脑脊液(CSF)漏和神经痛缓解。分别使用logit变换和Mantel-Haenszel方法计算分类数据的结局合并比例和OR(95%CI)。
纳入了6项研究,共1143例患者,其中618例患者的SPV被牺牲。血管相关并发症的合并比例(95%CI)值为3.82(0.87-15.17),新神经功能缺损为3.64(1.0-12.42),脑脊液漏为2.85(1.21-6.58),神经痛缓解为88.90(84.90-91.94)。荟萃分析得出结论,无论外科医生牺牲还是保留SPV,血管相关并发症(2.5%对1.5%,OR[95%CI]1.01[0.33-3.09],p=0.99)、新神经功能缺损(1.2%对2.8%,OR[95%CI]0.55[0.18-1.66],p=0.29)、脑脊液漏(3.1%对2.1%,OR[95%CI]1.16[0.46-2.94],p=0.75)和神经痛缓解(86.6%对87%,OR[95%CI]0.96[0.62-1.49],p=0.84)的几率相似。
牺牲SPV与保留SPV一样安全。作者建议,当轻柔牵拉无法改善手术视野可视化且外科医生遇到与SPV相关的神经血管冲突和/或预计会出现与SPV相关的出血时,有意牺牲SPV。